{
    "organizations": [],
    "uuid": "6711ddf0f631cdb7779894c934425e358edea761",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-xbiotech-announces-first-patient-i/brief-xbiotech-announces-first-patient-in-phase-2-study-evaluating-patients-with-atopic-dermatitis-idUSFWN1ST0DI",
    "ord_in_thread": 0,
    "title": "BRIEF-XBiotech Announces First Patient In Phase 2 Study Evaluating Patients With Atopic Dermatitis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 22 (Reuters) - XBiotech Inc:\n* XBIOTECH ANNOUNCES FIRST PATIENT IN PHASE 2 STUDY EVALUATING MABP1 IN PATIENTS WITH ATOPIC DERMATITIS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-22T20:44:00.000+03:00",
    "crawled": "2018-05-23T15:18:40.102+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "xbiotech",
        "inc",
        "xbiotech",
        "announces",
        "first",
        "patient",
        "phase",
        "study",
        "evaluating",
        "mabp1",
        "patient",
        "atopic",
        "dermatitis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}